Cello Group plc  

(Public, LON:CLL)   Watch this stock  
Find more results for Paul L. Chello
+0.45 (0.55%)
Oct 13 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 81.05 - 82.95
52 week 79.00 - 106.70
Open 82.50
Vol / Avg. 26,847.00/136,158.00
Mkt cap 70.61M*
P/E 77.96
Div/yield 0.84/3.18*
EPS 0.01*
Shares 85.28M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 1.32% 1.34%
Operating margin 2.43% 2.48%
EBITD margin - 6.26%
Return on average assets 1.68% 1.89%
Return on average equity 2.90% 3.32%
Employees 919 -
CDP Score - -


11-13 Charterhouse Buildings
United Kingdom - Map
+44-20-78128460 (Phone)
+44-20-72535376 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Cello Group plc is a United Kingdom-based company engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company's consumer facing clients. The Company's online digital community research platform, eVillage offers insights to clients. The Company has offices in the United Kingdom, the United States of America, Singapore and Hong Kong.

Officers and directors

Mark Scott Chief Executive, Executive Director
Mark Bentley Group Finance Director, Company Secretary, Executive Director
Stephen Highley Group Corporate Development Director, Director
Allan Rich Independent Non-Executive Chairman of the Board
William Nigel David Independent Non-Executive Director
Paul Hamilton Senior Independent Non Executive Director